RT team
Cadila Pharmaceuticals, a leading pharmaceutical company, has been named one of the “Top 50 Innovative Companies in India” at the prestigious CII Industrial Innovation Awards 2023. The recognition highlights the company’s dedication to groundbreaking advancements in the pharmaceutical sector.
Raj Prakash Vyas, President of Corporate Affairs at Cadila Pharmaceuticals, accepted the award at a ceremony attended by key industry figures. The event featured notable personalities such as Dr. Parvinder Maini and Vipin Sondhi.
Among the showcased innovations were Rabeloc IV, Sepsivac, Polycap, Resorine, Cadiflu, MycidacC, ThRabis, and more. Vyas emphasized that these innovations reflect the company’s commitment to addressing critical public health challenges and contributing to a healthier society.
The CII Industrial Innovation Awards, established in 2014, aim to recognize and celebrate innovative enterprises in various industry segments in India. Cadila Pharmaceuticals’ acknowledgment affirms its status as an innovation leader, contributing to healthcare advancements and setting new standards in the pharmaceutical landscape.
Cadila Pharmaceuticals, with a legacy spanning over seven decades, is globally recognized for creating innovative and affordable healthcare solutions. Committed to ethics, quality, and integrity, the company continues to impact healthcare delivery and strives to make affordable medicines accessible for a healthier world.
